Translational Research Cancer Centers Consortium


The Translational Research Cancer Centers Consortium (TRCCC) mission is to gain a greater understanding of the interactions between the immune system and cancer in the setting of biologic therapy of cancer.

The Translational Research Cancer Centers Consortium (TRCCC) was initiated in 1998 to expedite the progress in immunotherapy and other biologic therapies. TRCCC has seen a steady growth in member cancer centers and annual meeting participants over the past decade. The organization has successfully brought together leaders in this field to advance science, collaboration and clinical trials to help individuals diagnosed with cancer. The annual TRCCC meeting also provides a unique opportunity for trainees to present and interact in a supportive environment. 

Save the Date

2017 TRCCC Annual Meeting 

FEBRUARY 15-17, 2017

Gregory Beatty, M.D., Ph.D 
Carl June ,Ph.D
Daniel Powell, Ph. D 



2016 Annual Meeting Event Photos and Young Investigator Award Winners Posted 
Check out photos from the event and the winners of this year's Trainee Awards. Click here.  

Daniel J. Powell Jr., Ph.D.receives New Investigator Award from the American Society of Cell & Gene Therapy 
At the 17th Annual Meeting of the American Society of Gene & Cell Therapy, Daniel J. Powell Jr., Ph.D., research associate professor, Ovarian Cancer Research Center, Abramson Cancer Center, was presented with The Outstanding New Investigator Award. The Outstanding New Investigator awards are presented to individuals whose early achievements in the field demonstrate remarkable distinction. Dr. Daniel Powell's important contributions to T cell-based cancer therapy include elucidation of the role of CD27 in human T cell memory, development of a novel dual signaling approach to CAR-T cell therapy to limit toxicity, and identification of CD137 as a marker of naturally occurring tumor-reactive T cells. Click here to read more 

HBO features Dr. Carl June in VICE Special - Killing Cancer
T-Cell Therapy was the brainchild of Dr. Carl June, TRCCC Member and Director of Translational Research, University of Pennsylvania Abramson Cancer Center. In this special, the parents of a young girl suffering from acute lymphoblastic leukemia turn to the Children's Hospital of  Pennsylvania looking for a Phase I trial to save their daughter's life, as all other treatments had failed. The Phase I trial of Dr. June's T-Cell Therapy was their last chance for a cure and turned out to be just want the Whiteheads' young daughter needed for a new chance at life. Click here to watch the special.

2015 AAI Young Investigator Award Recipients Announced 

For the second year in a row, the American Association of Immunologists (AAI) supported the TRCCC Annual Meeting. This year, AAI contributed $2,000 for the Annual trainee awards. Click here to view a list of this year's winners. 

AAI Newsletter Highlights Support of TRCCC through the AAI Outreach Program
The AAI Outreach Program supports member-organized immunotherapy meetings. In the September-October 2014 issue of the AAI Newsletter they focused on the TRCCC Annual Meeting. To view the article in its entirety, click here.
TRCCC Member Carl H. June Receives 2014 Career Award from The American Association of Immunologists
The American Association of Immunologists proudly announced the 2014 recipients of the AAI Awards for outstanding research and career achievements. TRCCC Member, Carl H. June, M.D., professor of patholo­gy and laboratory medicine at the Perelman School of Medicine and director of transla­tional research, Abramson Cancer Center at the University of Pennsylvania, received the 2014 AAI - Steinman Award for Human Immunology Research. This award recognizes an individual who has made significant contributions to the understanding of immune processes underlying human disease pathogenesis, prevention, or therapy. Congratulations Dr. June! To view the entier list of winners, please click here

Website Builder